BACKGROUND Hand eczema (HE) is common and may follow a chronic disease course. So far, prospective studies investigating the risk factors for disease progression as a prerequisite for targeted prevention are scarce. OBJECTIVE To evaluate the overall association of HE-associated factors with clinical and quality of life (QoL) improvement during a follow-up of 2 years. METHODS Data of the prospective patient cohort (N = 199) followed by the Swiss chronic HE (CHE) registry on long-term patient management (CARPE-CH) were analysed by means of both classic regression and semantic map analyses. RESULTS Both severity of HE and QoL significantly improved over the period of 2 years (P < .001). However, 20% of patients had moderat...
Background: Hand eczema is a common disease seen in dermatological practice comprising of a spectrum...
BACKGROUND Itching is a leading symptom of chronic hand eczema (CHE) having a great impact on patien...
Background Antihistamines (AH) are often used to treat chronic skin diseases related to allergy and/...
Background Hand eczema (HE) is common and may follow a chronic disease course. So far, prospective s...
BACKGROUND Hand eczema (HE) is a common skin disease with major medical psychological and socio-e...
BackgroundHand eczema (HE) is a common skin disease with major medical psychological and socio-econo...
Contact eczema is the most common occupational skin disease, and it predominantly affects the hands....
Hand eczema (HE) is a common skin condition with a chronic course. Both genetics and contact allerge...
Background Data on the epidemiological impact and clinical characteristics of chronic hand eczema in...
Background: The CARPE registry was set up in 2009 to prospectively investigate the management of pat...
Background: Itching is a leading symptom of chronic hand eczema (CHE) having a great impact on pati...
Hand eczema has a high incidence and prevalence and has a negative impact on both physical and psych...
Hand eczema is considered a common disease. The exact prevalences however, are unknown. Studies esti...
BackgroundData on the epidemiological impact and clinical characteristics of chronic hand eczema in ...
The aim of the CARPE registry is to investigate characteristics and medical care in patients affecte...
Background: Hand eczema is a common disease seen in dermatological practice comprising of a spectrum...
BACKGROUND Itching is a leading symptom of chronic hand eczema (CHE) having a great impact on patien...
Background Antihistamines (AH) are often used to treat chronic skin diseases related to allergy and/...
Background Hand eczema (HE) is common and may follow a chronic disease course. So far, prospective s...
BACKGROUND Hand eczema (HE) is a common skin disease with major medical psychological and socio-e...
BackgroundHand eczema (HE) is a common skin disease with major medical psychological and socio-econo...
Contact eczema is the most common occupational skin disease, and it predominantly affects the hands....
Hand eczema (HE) is a common skin condition with a chronic course. Both genetics and contact allerge...
Background Data on the epidemiological impact and clinical characteristics of chronic hand eczema in...
Background: The CARPE registry was set up in 2009 to prospectively investigate the management of pat...
Background: Itching is a leading symptom of chronic hand eczema (CHE) having a great impact on pati...
Hand eczema has a high incidence and prevalence and has a negative impact on both physical and psych...
Hand eczema is considered a common disease. The exact prevalences however, are unknown. Studies esti...
BackgroundData on the epidemiological impact and clinical characteristics of chronic hand eczema in ...
The aim of the CARPE registry is to investigate characteristics and medical care in patients affecte...
Background: Hand eczema is a common disease seen in dermatological practice comprising of a spectrum...
BACKGROUND Itching is a leading symptom of chronic hand eczema (CHE) having a great impact on patien...
Background Antihistamines (AH) are often used to treat chronic skin diseases related to allergy and/...